Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catheter Location for Postoperative Analgesia in Nerve Blocks
NCT02523235Phase 4Completed
- Sponsor
- University of California, San Diego
- Start
- Aug 2015
- Primary completion
- Feb 2018
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by University of California, San Diego. Primary endpoint: Average Pain on Postoperative Day 1. Started Aug 2015; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02523235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02523235.